![Despite JAK 'anxiety,' ICER experts overwhelmingly back Incyte's ruxolitinib cream in atopic dermatitis | Fierce Pharma Despite JAK 'anxiety,' ICER experts overwhelmingly back Incyte's ruxolitinib cream in atopic dermatitis | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1627308868/GettyImages-1188977393.jpg?VersionId=UrvVZLhDksO0V10AsI7C70nbPiFq3UUn)
Despite JAK 'anxiety,' ICER experts overwhelmingly back Incyte's ruxolitinib cream in atopic dermatitis | Fierce Pharma
Incyte's Ruxolitinib Cream Meets Primary Endpoint in Phase 2 Trial for Vitiligo; Phase 3 Trials Planned
![Despite FDA holdups, Incyte's still counting on timely Jakafi, ruxolitinib cream verdicts | Fierce Pharma Despite FDA holdups, Incyte's still counting on timely Jakafi, ruxolitinib cream verdicts | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1628084153/jakafi.jpg/jakafi.jpg?VersionId=kbzfb.tl.v8DHVqmfrNZVzpJ_maVNSZu)
Despite FDA holdups, Incyte's still counting on timely Jakafi, ruxolitinib cream verdicts | Fierce Pharma
![Ruxolitinib cream proven safe, effective for atopic dermatitis | Latest news for Doctors, Nurses and Pharmacists | Pharmacy Ruxolitinib cream proven safe, effective for atopic dermatitis | Latest news for Doctors, Nurses and Pharmacists | Pharmacy](https://pubmiddleware.mims.com/resource/image/4F798D66-9FC3-47D8-80C4-A5CB00DCC830/OriginalThumbnail/THUMBNAIL_Fotolia_102116769_Subscription_Monthly_M.jpg)
Ruxolitinib cream proven safe, effective for atopic dermatitis | Latest news for Doctors, Nurses and Pharmacists | Pharmacy
![Incyte Corporation (INCY) Opzelura (ruxolitinib) cream FDA Approval Presentation - Slideshow (NASDAQ:INCY) | Seeking Alpha Incyte Corporation (INCY) Opzelura (ruxolitinib) cream FDA Approval Presentation - Slideshow (NASDAQ:INCY) | Seeking Alpha](https://static2.seekingalpha.com/uploads/sa_presentations/833/74833/slides/4.jpg?1632521613)